Showing results (201-210 of 315) with videos related to

Sort By:
Pageof 32
Haematologica|August 13, 2013
Alternative donor hematopoietic stem cell transplantation for mature lymphoid malignancies after reduced-intensity conditioning regimen: similar outcomes with umbilical cord blood and unrelated donor peripheral bloodCelso Arrais Rodrigues, Vanderson Rocha, Peter Dreger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2024
Improvements in Posttransplant Outcomes Over Two Decades in Older Patients with Acute Myeloid Leukemia in the EBMT ALWP StudyAli Bazarbachi, Myriam Labopin, Nour Moukalled, et al.
British Journal of Haematology|September 17, 2013
Targeted resequencing for analysis of clonal composition of recurrent gene mutations in chronic lymphocytic leukaemiaAlexander Jethwa, Jennifer Hüllein, Tatjana Stolz, et al.
The Lancet. Haematology|March 19, 2018
Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: retrospective follow-up of an open-label, randomised phase 3 trialFrederick Fasslrinner, Johannes Schetelig, Andreas Burchert, et al.
Molecular Systems Biology|August 12, 2022
Drug-microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLLPeter-Martin Bruch, Holly Ar Giles, Carolin Kolb, et al.
ESMO Open|October 24, 2020
Haematopoietic stem cell transplantation in adult soft-tissue sarcoma: an analysis from the European Society for Blood and Marrow TransplantationChristoph E Heilig, Manuela Badoglio, Myriam Labopin, et al.
Bioinformatics (Oxford, England)|February 8, 2017
ARResT/Interrogate: an interactive immunoprofiler for IG/TR NGS dataVojtech Bystry, Tomas Reigl, Adam Krejci, et al.
Bone Marrow Transplantation|May 2, 2022
Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemiaArnon Nagler, Christophe Peczynski, Bhagirathbhai Dholaria, et al.
European Journal of Cancer (Oxford, England : 1990)|March 25, 2017
Rituximab maintenance improves overall survival of patients with follicular lymphoma-Individual patient data meta-analysisLiat Vidal, Anat Gafter-Gvili, Gilles Salles, et al.
Haematologica|January 19, 2010
Allogeneic hematopoietic stem cell transplantation allows long-term complete remission and curability in high-risk Waldenström’s macroglobulinemia. Results of a retrospective analysis of the Société Française de Greffe de Moelle et de Thérapie CellulaireAlice Garnier, Marie Robin, Fabrice Larosa, et al.
Pageof 32